TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TYK Medicines, Inc. Class H ( (HK:2410) ) has issued an update.
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, held its 2025 second extraordinary general meeting on October 30, 2025. During the meeting, all proposed resolutions, including amendments to the Rules of Procedure for the Board of Directors and Shareholders’ General Meetings, and the adoption of the 2025 H Share Incentive Scheme, were approved by shareholders. The meeting was conducted in compliance with PRC Company Law and the Articles of Association, with Computershare Hong Kong Investor Services Limited serving as the scrutineer for vote-taking.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 11,145,754
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.75B
Learn more about 2410 stock on TipRanks’ Stock Analysis page.